Stage III Cutaneous Melanoma AJCC v7
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Frequently asked questions
How many drugs are in development for Stage III Cutaneous Melanoma AJCC v7?
BioSniper tracks 2 drugs in development for Stage III Cutaneous Melanoma AJCC v7 across 2 companies.
How many clinical trials target Stage III Cutaneous Melanoma AJCC v7?
There are 1 clinical trial targeting Stage III Cutaneous Melanoma AJCC v7 tracked by BioSniper.
What is the prevalence of Stage III Cutaneous Melanoma AJCC v7?
The estimated prevalence of Stage III Cutaneous Melanoma AJCC v7 is approximately 75.0 per 100,000 population.
Deep-dive into Stage III Cutaneous Melanoma AJCC v7
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis